Related Experiment Video
Updated: Jan 13, 2026
08:56
Nerve Ultrasound Protocol to Detect Dysimmune Neuropathies
Published on: October 7, 2021
3.2K
Cryptogenic Sensory Polyneuropathy and Metabolic Syndrome.
Mamatha Pasnoor1, Mazen M Dimachkie2, Richard J Barohn3
1Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.
Neurologic Clinics
|October 29, 2025
Summary
This review clarifies diagnosing cryptogenic sensory polyneuropathy (CSPN). It highlights key clinical features and emphasizes excluding other causes before diagnosis, noting that extensive testing is often unnecessary.
Area of Science:
- Neurology
- Clinical Medicine
Background:
- Cryptogenic sensory polyneuropathy (CSPN) presents diagnostic challenges.
- Metabolic syndrome and other etiologies can mimic CSPN.
Purpose of the Study:
- To review the epidemiology and clinical features of CSPN.
- To outline diagnostic criteria and differential diagnoses for CSPN.
- To discuss appropriate management strategies for CSPN.
Main Methods:
- Literature review focusing on epidemiological data and clinical characteristics.
- Analysis of diagnostic criteria and exclusion of alternative neuropathies.
- Evaluation of treatment modalities for CSPN.
Main Results:
- Diagnosis relies on specific clinical features and exclusion of other causes.
- Extensive testing for autoimmune or hereditary neuropathies is generally not required.
- Metabolic syndrome is a significant differential diagnosis to consider.
Conclusions:
- CSPN diagnosis requires careful clinical assessment and exclusion of common etiologies.
- Symptomatic treatment is the primary approach; autoimmune therapies are not indicated.
- Further research into CSPN pathogenesis may refine diagnostic and therapeutic strategies.
Related Concept Videos
01:19Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
01:20Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
01:20Inborn Errors of Metabolism
691
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
691
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
01:24Nephrotic Syndrome I : Introduction
488
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
488
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
346
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
346